• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Catalog Number VAMF2626C100TU
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code Fistula (1862)
Date of Event 06/15/2025
Type of Reportable Event Serious Injury
Event or Problem Description
A valiant captivia stent grafts was implanted during the treatment of a penetrating aortic ulcer (pau) procedure.Per the operative notes, the patient was known to have a infected aorta at the time and before implanting the graft, the surgeon soaked the stent graft in an antibiotic called revampin.The patient was lost to follow and was not taking antibiotics to get rid of the infection.  approximately 46 months post index procedure, a ct noted an aorto-eosophageal fistula (aef) and an intercostal type ii endoleak.Re -lining was performed on the same date using a new valiant captivia device due to the need for an eosophagectomy for the aef.Prior to the re-lining procedure, the new graft was soaked in an antibiotic also before implanting.Per the physician the source or cause of the infection is unknown.Per the physician, the aef was associated with the tevar procedure/device.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - FF
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key22435069
Report Number9612164-2025-03341
Device Sequence Number3152513
Product Code MIH
UDI-Device Identifier00643169347106
UDI-Public(01)00643169347106(17)230217
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
P100040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/17/2023
Device Catalogue NumberVAMF2626C100TU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/15/2025
Initial Report FDA Received Date07/08/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/17/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
Patient SexFemale
-
-